Saratov JOURNAL of Medical and Scientific Research

On the relationship between innate and adaptive immunity in psoriasis

Year: 2015, volume 11 Issue: №3 Pages: 421-423
Heading: Dermatovenerology Article type: Review
Authors: Nikolashina О.Е., Bakulev A.L.
Organization: Penza Regional Clinical Center of specialized types of medical care, Saratov State Medical University

There is an overview of the current literature data, which reflects the key aspects of the etiology and pathogenesis of psoriasis. A genetically determined, multifactorial nature of the dermatosis was displayed. There were summarized numerous domestic and foreign data on immunological (cellular, humoral, mediator, extravasation, angiogenesis) and non-immune mechanisms of genesis of psoriasis.

1. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimar sson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004; 135(1): 1-8
2. Kastelan M, Massari LP, Pasic A, Gruber F. New trends in the immunopathogenesis of psoriasis. Acta Dermatovenerol Croat 2004; 12(1): 26-29
3. Ortonne JP Redefining clinical response in psoriasis: targeting the pathological basis of disease. J Drugs Dermatol 2004; 3(1): 13-20
4. Perlamutrov YN, Solov'ev AM. Psoriasis and modern methods of treatment. Therapist 2004; (5): 38-43
5. Lench N, lies MM, Mackay I, et al. Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatability complex haplotype for psoriasis in a Caucasian population. J Invest Dermatol 2005; 124 (3): 545-552
6. Rie MA, Goedkoop AY, Bos JD. Overview of psoriasis. Dermatol Ther2004; 17 (5): 341-349
7. Korotkij NG, Udzhuhu VY, Dvornikova TV. Modern approaches to the treatment of erythrodermic psoriasis. Ros. zhurn. leather, and Venus, diseases. 2001; (1): 7-11
8. Mukhtar R, Choi J, Коо JY Quality-of-life issues in psoriasis. Dermatol Clin 2004; 22 (4): 389-395
9. Marinina GN, Marinin VS. Treatment of psoriasis. 4th ed., rev. Kharkov: Spectrum, 2000. 104 p.
10. Belie D, Ristic-Nikolic S, Damjan S, et al. Heredity of psoriasis. Med Pregl. 2004; 57 (3-4): 171-174
11. Sagoo GS, Cork MJ, Patel R, Tazi-Ahnini R. Genome-wide studies of psoriasis susceptibility loci. J Dermatol Sci 2004; 35(3): 171179
12. Gupta R, Debbaneh MG, Liao W. Genetic Epidemiology of Psoriasis. Curr Dermatol Rep 2014; 3 (1): 61-78
13. Vasilca V, Vasilca A, Munteanu D, et al. HLA-B57 is significantly associated with psoriasis in Northeast Romania. Roum Arch Microbiol Immunol 2002; 61 (4): 259-265
14. Bahcetepe N, Kutlubay Z, Yilmaz E, Tuzun Y, Eren B. The role of HLA antigens in the aetiology of psoriasis. Med Glas (Zenica) 2013, 10 (2): 339-342
15. Ammar M, Souissi-Bouchlaka C, Gati A, et al. Psoriasis: physiopathology and immunogenetics. Pathol Biol (Paris) 2014; 62(1): 10-23
16. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007; 25 (6): 563-567. 17. Elder JT, Henseler T, Christophers E. The genetic of psoriasis. Arch Dermatol 1994; 130: 216-224
18. Tomfohrde J, Silverman A, Barnes R. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264: 1141-1145
19. Matthews D, PowlesA. V, Fry L. Conformation of genetic heterogeneity in familial psoriasis. J Invest Dermatol 1995; 105 (3): 457-461
20. Mordovtsev VN, Sukolin Gl, Sergeev AS. Epidemiology and genetics of psoriasis. In: Symposium on psoriasis dermatovenerologists socialist countries, 3rd: tez.dokl. Moscow, 1987; 89 p.
21. Vasileysky SS. The relationship of immunological and non-immune factors, the pathogenesis of psoriasis. Vestnik of Dermatology and Venereology 1990 (9): 26-29
22. Prinz JC. The role of T cells in psoriasis. Eur Acad Dermatol Venereol 2003; 17 (3): 257270
23. Prinz JC. Which T cells cause psoriasis? Clin Exp Dermatol 1999; 24 (4): 291-295
24. Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin 2015; 33 (1): 13-23
25. Coimbra S, FigueiredoA, Castro E, et al.The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol 2012; 51 (4): 389-395
26. Alshenawy HA, Hasby EA. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis. Cell Immunol 2011; 269 (2): 115-119
27. Mabrijan L. Adhesion molecules in keratinocytes. Clin Dermatol 2011; 29 (4): 427-431
28. Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 1994; 21 (4): 223-232
29. Cabrijan L, Batinac T, Lenkovic M, Gruber F. The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses 2009; 72 (3): 327-329
30. Christophers E, Metzler G, R4cken M. Bimodal immune activation in psoriasis. Br J Dermatol. 2014, 170 (1): 59-65
31. Shegay MM, Keshileva ZB, Akyshbaeva G. A The role of certain cytokines in the development of psoriasis. Vestnik of Dermatology and Venereology 1998; (5): 7-12
32. Varricchi G, Granata F, Loffredo S, Genovese A, Marone G. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol 2015; 73 (1): 144-153
33. Mitsui A, Tada Y, Shibata S, et al. Deficiency of both L-selectin and ICAM-1 exacerbates imiquimod-induced psoriasislike skin inflammation through increased infiltration of antigen presenting cells. Clin Immunol 2015; 157 (1): 43-55
34. Li W, Man XY, Chen JQ, Zhou J, Cai SQ. Zheng MTargeting VEGF/VEGFR in the treatment of psoriasis. Discov Med2014, 18 (98): 97-104
35. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24 (6): 737-764
36. Ramirez-Bosca A, Martinez-Ojeda L, Valcuende-Cavero F, Castells-RodellasA. A study of local immunity in psoriasis. BrJ Dermatol 1988; 119 (5): 587-595
37. Ivanova IP, Mareeva ТЕ. Violations of lipid peroxidation, activity of lysosomal hydrolases and their correction in patients with psoriasis. Vestnik of Dermatology and Venereology 1987; (4): 26-31
38. Shilov VN, Sergienko VI. New approaches to the study of the pathogenesis and treatment of psoriasis. Vestnik of Dermatology and Venereology 1998; (3): 49-52
39. Kapuscinska R, Wysocka J, Zelazowska В, Niczyporuk W. Evaluation of neutrophils adhesive molecules CD11b/CD18 in course of photochemotherapy (PUVA) psoriasis vulgaris. Pol Merkuriusz Lek. 2004; 16 (96): 547-550
40. BakulevAL, Whistlers AA, Kravchenya SS. Some of the clinical and immunological features of endotoxemia in psoriasis
41. Bakulev AL, Kravchenya SS. Psoriasis of the scalp: new opportunities topical therapy. Journal of Dermatology and Venereology 2013; (2): 73-78.

2015_03-01_421-423.pdf252.22 KB

No votes yet